Bluebird’s Eli-Cel Gene Therapy Gets US Panel Nod For Some Cerebral Adrenoleukodystrophy Patients

 
• By Sue Sutter
Scale
The clinical benefit seen with eli-cel outweighs the risk of myelodysplastic syndrome, an FDA panel said. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers